Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin
- PMID: 8589726
- DOI: 10.1038/ng0396-318
Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin
Abstract
The sterility of male and female homozygous ob/ob mice is a recognized feature of the ob mutation (1). Whereas ob/ob males can occasionally reproduce if maintained on a restricted diet, ob/ob females are always sterile (2). Thinning of the ob/ob females to normal weight by diet-restriction failed to correct their sterility. Early sexual development is normal in ob/ob females; however, ovulation never follows and the mice remain prepuberal indefinitely with no occurrence of oestrus cycles. Reproductive hormones are reduced in ob/ob females (3) demonstrating a functional defect from the hypothalamic-pituitary axis (4-6). The ovaries of ob/ob females are capable of producing viable eggs when transplanted into lean female recipients (7). Reconstitution of reproductive functions in the ob/ob female necessitates delivery of hypothalamic extracts to the third ventricle (8) and administration of pituitary extract (9), gonadotropic hormones (10), progesterone (11) and relaxin (12). These previous findings demonstrate that the sterility of ob/ob females is caused by an insufficiency of hormones at the hypothalamic-pituitary level rather than physical hindrance of copulatory activity, pregnancy and parturition caused by excess adipose tissue. We show here that repeated administration of only the recombinant human ob protein, leptin, into homozygous female ob/ob mice can correct their sterility, thus resulting in ovulation, pregnancy and parturition.
Similar articles
-
Effects of leptin replacement on hypothalamic-pituitary growth hormone axis function and circulating ghrelin levels in ob/ob mice.Am J Physiol Endocrinol Metab. 2007 Mar;292(3):E891-9. doi: 10.1152/ajpendo.00258.2006. Epub 2006 Nov 22. Am J Physiol Endocrinol Metab. 2007. PMID: 17122091
-
Increased expression of hypothalamic leptin receptor and adiponectin accompany resistance to dietary-induced obesity and infertility in female C57BL/6J mice.Int J Obes (Lond). 2007 Mar;31(3):395-402. doi: 10.1038/sj.ijo.0803392. Epub 2006 Jul 25. Int J Obes (Lond). 2007. PMID: 16865100
-
Leptin treatment markedly increased plasma adiponectin but barely decreased plasma resistin of ob/ob mice.Am J Physiol Endocrinol Metab. 2004 Sep;287(3):E446-53. doi: 10.1152/ajpendo.00488.2003. Epub 2004 May 4. Am J Physiol Endocrinol Metab. 2004. PMID: 15126241
-
[ob protein--product of expressing an obesity gene and some aspects of modern-day endocrinology].Biokhimiia. 1996 Jun;61(6):984-92. Biokhimiia. 1996. PMID: 9011250 Review. Russian.
-
[Leptin--a peptide hormone from adipocytes. Sensation of the 23rd FEBS Meeting].Bioorg Khim. 1996 Mar;22(3):228-33. Bioorg Khim. 1996. PMID: 8687512 Review. Russian.
Cited by
-
Novel perspectives on leptin in osteoarthritis: Focus on aging.Genes Dis. 2023 Nov 4;11(6):101159. doi: 10.1016/j.gendis.2023.101159. eCollection 2024 Nov. Genes Dis. 2023. PMID: 39229323 Free PMC article. Review.
-
Implications of pregnancy on cardiometabolic disease risk: preeclampsia and gestational diabetes.Am J Physiol Cell Physiol. 2024 Sep 1;327(3):C646-C660. doi: 10.1152/ajpcell.00293.2024. Epub 2024 Jul 16. Am J Physiol Cell Physiol. 2024. PMID: 39010840 Review.
-
The effects of leptin on human cytotrophoblast invasion are gestational age and dose-dependent.Front Endocrinol (Lausanne). 2024 May 23;15:1386309. doi: 10.3389/fendo.2024.1386309. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38846494 Free PMC article.
-
Dysfunction of the adhesion G protein-coupled receptor latrophilin 1 (ADGRL1/LPHN1) increases the risk of obesity.Signal Transduct Target Ther. 2024 Apr 26;9(1):103. doi: 10.1038/s41392-024-01810-7. Signal Transduct Target Ther. 2024. PMID: 38664368 Free PMC article.
-
Longitudinal cytokine and multi-modal health data of an extremely severe ME/CFS patient with HSD reveals insights into immunopathology, and disease severity.Front Immunol. 2024 Apr 8;15:1369295. doi: 10.3389/fimmu.2024.1369295. eCollection 2024. Front Immunol. 2024. PMID: 38650940 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous